We are live on ! Find out more
PRCT icon

Procept Biorobotics
PRCT

116 hedge funds and large institutions have $1.36B invested in Procept Biorobotics in 2022 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 47 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 10

57% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 30

17% more funds holding in top 10

Funds holding in top 10: 6 → 7 (+1)

13% more funds holding

Funds holding: 103 → 116 (+13)

3% less capital invested

Capital invested by funds: $1.4B → $1.36B (-$36.1M)

2.31% less ownership

Funds ownership: 75.52% → 73.2% (-2.3%)

92% less call options, than puts

Call options by funds: $656K | Put options by funds: $7.86M

Holders
116
Holders Change
+13
Holders Change %
+12.62%
% of All Funds
1.86%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.11%
New
24
Increased
47
Reduced
30
Closed
10
Calls
$656K
Puts
$7.86M
Net Calls
-$7.2M
Net Calls Change
+$31K

Top Buyers

1
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$25M
2
YU
Yale University
Connecticut
+$24M
3
Citadel Advisors
Citadel Advisors
Florida
+$20M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$17M
5
Millennium Management
Millennium Management
New York
+$11M

Top Sellers

1
CI
CPMG Inc
Texas
-$160M
2
JJ
Johnson & Johnson
New Jersey
-$21.7M
3
PA
Perceptive Advisors
New York
-$8.55M
4
PAMP
Polar Asset Management Partners
Ontario, Canada
-$4.03M
5
Invesco
Invesco
Georgia
-$3.42M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$272M +$3.93M +91,609 +1%
CI
2
CPMG Inc
Texas
$221M -$160M -3,726,474 -41%
Vanguard Group
3
Vanguard Group
Pennsylvania
$134M +$17M +396,340 +14%
T. Rowe Price Investment Management
4
T. Rowe Price Investment Management
Maryland
$112M +$5.33M +124,102 +5%
BlackRock
5
BlackRock
New York
$79M +$3.96M +92,320 +5%
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$48.5M +$4.18M +97,383 +9%
DCM
7
Driehaus Capital Management
Illinois
$36.8M +$632K +14,716 +2%
BG
8
Bellevue Group
Switzerland
$30.8M +$6.54M +152,255 +26%
State Street
9
State Street
Massachusetts
$29.4M +$1.95M +45,510 +7%
Citadel Advisors
10
Citadel Advisors
Florida
$27.8M +$20M +465,055 +227%
Loomis, Sayles & Company
11
Loomis, Sayles & Company
Massachusetts
$24.2M +$25M +582,617 New
Geode Capital Management
12
Geode Capital Management
Massachusetts
$23.3M +$1.43M +33,203 +6%
YU
13
Yale University
Connecticut
$23.2M +$24M +558,535 New
FRA
14
Frank Rimerman Advisors
California
$22.1M -$1.75M -40,835 -7%
PHS
15
PFM Health Sciences
California
$21.5M – – –
Millennium Management
16
Millennium Management
New York
$19.3M +$11M +255,715 +123%
Massachusetts Financial Services
17
Massachusetts Financial Services
Massachusetts
$15.2M +$50.2K +1,170 +0.3%
JJ
18
Johnson & Johnson
New Jersey
$14.9M -$21.7M -505,969 -59%
Mirae Asset Global Investments
19
Mirae Asset Global Investments
South Korea
$12.7M -$620K -14,432 -5%
N
20
Nuveen
North Carolina
$11.7M +$1.31M +30,464 +12%
Bank of America
21
Bank of America
North Carolina
$11M -$376K -8,759 -3%
Northern Trust
22
Northern Trust
Illinois
$9.74M +$233K +5,419 +2%
Charles Schwab
23
Charles Schwab
California
$9.43M +$253K +5,892 +3%
ACM
24
Atika Capital Management
New York
$8.3M +$3.38M +78,765 +65%
First Trust Advisors
25
First Trust Advisors
Illinois
$6.83M +$3.78M +88,141 +116%
1
2 3 4 5

PRCT Hedge Fund Activity: Q4 2022 in Review

116 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q4 2022, worth a combined $1.36B — down 2.6% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new PRCT positions and 10 closed out — a net gain of 14 holders — while 47 added to existing stakes and 30 trimmed.

The largest buyer was Loomis, Sayles & Company, opening a new position worth an estimated $25M. The largest seller was CPMG Inc, cutting an estimated $160M.

  • 116 institutional investors held Procept Biorobotics (PRCT) as of Q4 2022, up from 103 in Q3 2022.
  • Funds reported $1.36B of Procept Biorobotics stock for Q4 2022, down 2.6% quarter-over-quarter.
  • 24 funds opened new Procept Biorobotics positions in Q4 2022 and 10 closed out, a net change of +14 holders.
  • The largest Procept Biorobotics buyer in Q4 2022 was Loomis, Sayles & Company, an estimated $25M added.
  • The largest Procept Biorobotics seller in Q4 2022 was CPMG Inc, an estimated $160M sold.

Based on aggregated 13F filings for Q4 2022.